02 / Research topics
Potential PhD Research Topics in Human Genetics
Explore suggested topics and the methods, tools and expertise that could support each investigation.
1
Interpreting Noncoding Genetic Variants Through Single Cell Regulatory Genomics
Investigate why most disease-associated variants lie outside protein-coding regions yet remain functionally unexplained. The gap is limited cell-type-specific evidence linking variants to regulatory mechanisms and phenotypes. This project would integrate population genetics, single-cell multiomics, enhancer assays, and genome editing to identify causal variants and target genes across relevant tissues. Objectives include prioritizing variants, validating regulatory effects, modeling gene networks, and developing interpretable prediction frameworks for disease risk and therapeutic discovery.
Applications and use cases
2
Long Read Genomics for Resolving Structural Variants in Rare Disease
Develop a comprehensive framework for detecting and interpreting complex structural variants that short-read sequencing frequently misses. The unmet need is especially severe for patients with unresolved rare diseases, repeat expansions, mobile-element insertions, and highly repetitive genomic regions. The research should combine long-read sequencing, assembly-based analysis, phenotype-driven prioritization, and functional validation. Objectives include improving diagnostic yield, discovering pathogenic mechanisms, benchmarking algorithms across ancestries, and establishing clinically practical workflows for difficult genomic cases.
Applications and use cases
3
Ancestry-Aware Polygenic Risk Prediction for Equitable Precision Medicine
Decode how polygenic risk scores lose accuracy when developed predominantly from European-ancestry datasets. The central gap concerns portability, calibration, and clinical usefulness across globally diverse populations. This proposal would construct ancestry-aware models using diverse biobanks, local ancestry inference, trans-ancestry methods, and transparent validation. Objectives include improving prediction fairness, quantifying environmental interactions, evaluating clinical utility, and creating reporting standards that prevent genetic risk estimates from widening existing health disparities.
Applications and use cases
4
Single Cell Multiomics of Human Development and Congenital Disorders
Evaluate how genetic variants disrupt cell-state transitions during human embryonic and organ development. Current models often lack temporal resolution, relevant human tissues, or integrated molecular measurements, limiting understanding of congenital disorders. The project could combine organoids, donated fetal tissues where ethically appropriate, single-cell multiomics, spatial profiling, and perturbation screens. Objectives include constructing developmental cell atlases, identifying vulnerable windows, linking variants to disrupted pathways, and discovering intervention opportunities for developmental disease.
Applications and use cases
5
Functional Genomics of Gene–Environment Interactions in Complex Disease
Integrate genetic, environmental, and molecular data to explain why individuals with similar inherited risk develop different disease outcomes. Existing studies often treat environmental exposures as crude variables and lack mechanistic validation. This research would combine longitudinal cohorts, exposomics, epigenomics, transcriptomics, and controlled cellular models. Objectives include identifying exposure-sensitive genetic pathways, distinguishing correlation from causation, estimating critical life-course windows, and developing biologically informed prevention strategies for complex diseases.
Applications and use cases
6
Population Genomics of Immunity and Infectious Disease Susceptibility
Characterize how human genetic diversity shapes susceptibility, severity, and recovery from infectious diseases. Major gaps remain in underrepresented populations, pathogen-specific host responses, and the interaction between inherited variation and immune history. This project would integrate host whole-genome data, pathogen sequencing, immune phenotyping, and longitudinal clinical records. Objectives include discovering protective and harmful variants, separating ancestry from causal biology, identifying immune pathways, and informing vaccines, therapeutics, and outbreak preparedness.
Applications and use cases
7
CRISPR Based Functional Validation of Patient Specific Disease Variants
Engineer scalable experiments to determine which patient-specific variants truly cause disease and through what mechanisms. Although sequencing produces many candidate variants, clinical interpretation remains constrained by limited functional evidence and inconsistent assay relevance. The study would combine genome editing, induced pluripotent stem cell models, high-content phenotyping, and transcriptomic profiling. Objectives include creating isogenic controls, measuring variant effects in disease-relevant cell types, improving variant classification, and establishing reproducible evidence pipelines for precision diagnosis.
Applications and use cases
8
Epigenomic Mechanisms Linking Early Life Exposures With Adult Disease
Clarify how prenatal and early-life exposures produce durable molecular changes associated with adult disease. The field lacks robust causal evidence, tissue-aware biomarkers, and understanding of reversibility across the life course. This proposal would combine birth cohorts, repeated biosampling, methylation and chromatin profiling, genetic instrumental variables, and experimental validation. Objectives include identifying persistent epigenetic signatures, distinguishing inherited from exposure-induced effects, testing tissue specificity, and evaluating whether findings can guide early prevention.
Applications and use cases
9
Genomic Architecture and Molecular Mechanisms of Neuropsychiatric Disorders
Quantify how rare variants, common polygenic effects, regulatory networks, and cell-type vulnerabilities converge in neuropsychiatric disorders. Current research is limited by diagnostic heterogeneity, incomplete representation of diverse populations, and weak links between statistical associations and neural mechanisms. The project should integrate large-scale genetics with brain single-cell datasets, patient-derived neural models, and network analysis. Objectives include identifying convergent pathways, improving biologically informed subtyping, and prioritizing targets for therapeutic development.
Applications and use cases
10
Translating Pharmacogenomic Variation Into Safer Individualized Drug Therapy
Translate genetic variation into clinically actionable prescribing strategies that improve efficacy and reduce adverse drug reactions. Although pharmacogenomic associations are established for several medicines, implementation remains inconsistent because of ancestry bias, incomplete evidence, and uncertain clinical workflows. This research would combine diverse clinical cohorts, electronic prescribing data, functional assays, and implementation science. Objectives include validating gene–drug effects, improving dosing algorithms, measuring health outcomes, and designing equitable systems for routine genomic decision support.
Applications and use cases